JP2020510438A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510438A5
JP2020510438A5 JP2019548921A JP2019548921A JP2020510438A5 JP 2020510438 A5 JP2020510438 A5 JP 2020510438A5 JP 2019548921 A JP2019548921 A JP 2019548921A JP 2019548921 A JP2019548921 A JP 2019548921A JP 2020510438 A5 JP2020510438 A5 JP 2020510438A5
Authority
JP
Japan
Prior art keywords
antibody
target polypeptide
cell population
cell
mammalian cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019548921A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510438A (ja
Filing date
Publication date
Priority claimed from GBGB1704115.3A external-priority patent/GB201704115D0/en
Application filed filed Critical
Publication of JP2020510438A publication Critical patent/JP2020510438A/ja
Publication of JP2020510438A5 publication Critical patent/JP2020510438A5/ja
Priority to JP2023159291A priority Critical patent/JP2024001060A/ja
Pending legal-status Critical Current

Links

JP2019548921A 2017-03-15 2018-03-14 抗体の選択方法 Pending JP2020510438A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023159291A JP2024001060A (ja) 2017-03-15 2023-09-23 抗体の選択方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1704115.3 2017-03-15
GBGB1704115.3A GB201704115D0 (en) 2017-03-15 2017-03-15 Method of selecting for antibodies
PCT/GB2018/050645 WO2018167481A1 (en) 2017-03-15 2018-03-14 Method of selecting for antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023159291A Division JP2024001060A (ja) 2017-03-15 2023-09-23 抗体の選択方法

Publications (2)

Publication Number Publication Date
JP2020510438A JP2020510438A (ja) 2020-04-09
JP2020510438A5 true JP2020510438A5 (enExample) 2021-04-22

Family

ID=58605467

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019548921A Pending JP2020510438A (ja) 2017-03-15 2018-03-14 抗体の選択方法
JP2023159291A Pending JP2024001060A (ja) 2017-03-15 2023-09-23 抗体の選択方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023159291A Pending JP2024001060A (ja) 2017-03-15 2023-09-23 抗体の選択方法

Country Status (9)

Country Link
US (1) US20200072820A1 (enExample)
EP (1) EP3596128A1 (enExample)
JP (2) JP2020510438A (enExample)
KR (1) KR102499955B1 (enExample)
CN (1) CN110382548A (enExample)
AU (1) AU2018234291A1 (enExample)
GB (1) GB201704115D0 (enExample)
SG (1) SG11201907925WA (enExample)
WO (1) WO2018167481A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110892064A (zh) 2017-07-25 2020-03-17 牛津遗传学有限公司 腺病毒载体
GB201901571D0 (en) 2019-02-05 2019-03-27 Oxford Genetics Ltd Inducible AAV sysyem
CN113544509A (zh) * 2019-03-08 2021-10-22 牛津遗传学有限公司 选择抗体的方法
GB201903233D0 (en) 2019-03-08 2019-04-24 Oxford Genetics Ltd Method of selecting for antibodies
EP4200434A4 (en) * 2020-08-21 2024-10-02 Hifibio (Shanghai) Co., Ltd. FUNCTIONAL SCREENING USING DROPLET MICROFLUIDIC

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04234987A (ja) * 1990-12-28 1992-08-24 Mitsubishi Kasei Corp Dna断片
US20140072979A1 (en) * 2001-01-16 2014-03-13 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
US6919183B2 (en) * 2001-01-16 2005-07-19 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
JP2005502645A (ja) * 2001-08-08 2005-01-27 ザ ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム 細胞特異的プロモーターからの発現を増幅するための方法
WO2008118476A2 (en) * 2007-03-26 2008-10-02 Codon Devices, Inc. Cell surface display, screening and production of proteins of interest
WO2009103753A1 (en) * 2008-02-20 2009-08-27 Ablynx Nv Methods for identifying and/or sorting cells by secreted molecule and kits for performing such methods
JP2009268399A (ja) * 2008-05-07 2009-11-19 Tosoh Corp 抗体に結合可能な蛋白質発現ミエローマおよびこれを用いる細胞融合方法並びに交雑細胞およびその選別方法
US20120101000A1 (en) * 2008-11-21 2012-04-26 Chen Zhou High complexity mammalian display library and methods of screening
US9365846B2 (en) * 2010-12-01 2016-06-14 Merck Sharp & Dohme Corp. Surface, anchored Fc-bait antibody display system
WO2014031068A1 (en) * 2012-08-21 2014-02-27 Medetect Ab Method for improved cell identification
US9487773B2 (en) * 2013-03-01 2016-11-08 Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa Cell-based methods for coupling protein interactions and binding molecule selection

Similar Documents

Publication Publication Date Title
JP2020510438A5 (enExample)
Ng et al. A comprehensive library of human transcription factors for cell fate engineering
Mukherjee et al. Methodologies to decipher the cell secretome
Castagnaro et al. Nkx2-5+ islet1+ mesenchymal precursors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity
Shibata et al. Modeling embryo-endometrial interface recapitulating human embryo implantation
Konkimalla et al. Transitional cell states sculpt tissue topology during lung regeneration
Vebr et al. A narrative review of cytokine networks: pathophysiological and therapeutic implications for inflammatory bowel disease pathogenesis
JP2015529826A5 (enExample)
HRP20240408T1 (hr) Inzulin-fc fuzijski proteini ultradugog djelovanja i metode uporabe
RU2017134741A (ru) Полипептиды транспозазы и их применение
Sharma et al. The rise of retinal organoids for vision research
Hartl et al. Cis-regulatory landscapes of four cell types of the retina
JP2012516686A5 (enExample)
AR109451A1 (es) Composiciones y métodos para preparar anticuerpos basados en el uso de loci mejoradores de expresión
Lee et al. Development of the “Three-step MACS”: a novel strategy for isolating rare cell populations in the absence of known cell surface markers from complex animal tissue
Bhattacharyya et al. Macrophage Cx43 is necessary for fibroblast cytosolic calcium and lung fibrosis after injury
Kim et al. Rap1 controls epiblast morphogenesis in sync with the pluripotency states transition
ATE320484T1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
Nadarajah et al. A novel splice-site mutation in VEGFC is associated with congenital primary lymphoedema of gordon
Hess et al. In vivo partial reprogramming by bacteria promotes adult liver organ growth without fibrosis and tumorigenesis
Al Madhoun et al. Comparative proteomic analysis identifies EphA2 as a specific cell surface marker for Wharton’s jelly-derived mesenchymal stem cells
Schäck et al. Expression of CD24 in Human Bone Marrow‐Derived Mesenchymal Stromal Cells Is Regulated by TGFβ3 and Induces a Myofibroblast‐Like Genotype
CN110382548A (zh) 选择抗体的方法
Buono et al. Human plaque myofibroblasts to study mechanisms of atherosclerosis
Farhat et al. Understanding the cell fate and behavior of progenitors at the origin of the mouse cardiac mitral valve